| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol.2019;25(3):283-293.   Published online November 13, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0054
                              Supplementary         Cited By 1
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2014;20(3):274-282.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.274
                                 Cited By 1
Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection
Yoon Jun Kim , Hyo Suk Lee
Korean J Hepatol.2009;15(1):7-14.   Published online March 31, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.1.7
         Cited By 3
A case report of treatment with pegylated interferon alpha for Lamivudine-resistant chronic hepatitis B virus infection
Won Haing Hur , Hyun Young Woo , Soung Won Jeong , Chan Ran You , Si Hyun Bae , Jong Young Choi , Seung Kew Yoon
Korean J Hepatol.2008;14(4):513-518.   Published online December 31, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.4.513
      
The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B
Hyung Joon Kim
Korean J Hepatol.2008;14(3):411-416.   Published online September 30, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.3.411
      
The Korean Journal of Adefovir plus Lamivudine combination therapy in Lamivudine-resistant chronic hepatitis B
So Young Kwon
Korean J Hepatol.2008;14(2):235-239.   Published online June 20, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.2.235
      
The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis
Yeon Seok Seo
Korean J Hepatol.2008;14(1):116-121.   Published online March 20, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.1.116
      
Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment
Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.1
Korean J Hepatol.2007;13(4):513-520.   Published online December 20, 2007     
DOI: https://doi.org/10.3350/kjhep.2007.13.4.513
      
The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B
Young-Myoung Moon, M.D.1, Seong-Gyu Hwang, M.D.2, Boo-Sung Kim, M.D.3, Kyu-Sung Rim, M.D.2, Mong Cho, M.D.4, Dong-Joon Kim, M.D.5, Joon-Yeol Han, M.D.6, Young-Seok Kim, M.D.3, Ho-Soon Choi, M.D.7, Sang-Hoon Ahn, M.D.8
Korean J Hepatol.2007;13(4):503-512.   Published online December 20, 2007     
DOI: https://doi.org/10.3350/kjhep.2007.13.4.503
         Cited By 5
Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
In Hee Kim , Seong Hun Kim , Hyun Chul Kim , Kyoung Deok Shin , Sang Wook Kim , Seong Ok Lee , Soo Teik Lee , Dae Ghon Kim
Korean J Hepatol.2007;13(3):349-362.   Published online September 20, 2007     
DOI: https://doi.org/10.3350/kjhep.2007.13.3.349
         Cited By 1
Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection
Jeong Heo , Mong Cho , Byung Mann Cho , Sun Mi Lee , Tae Oh Kim , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song
Korean J Hepatol.2007;13(2):157-165.
      
Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT
Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim
Korean J Hepatol.2007;13(2):146-156.
      
Clinical Significances of Serum Soluble Fas and Soluble Fas Ligand in Chronic Hepatitis B
Eun Jung Jun, M.D., Joon-Yeol Han, M.D., and Hee Sik Sun, M.D.1
Korean J Hepatol.2006;12(4):507-514.
      
Resistance to Adefovir in Patients with Chronic Hepatitis B
Soo Hyung Ryu, M.D.,* Young-Hwa Chung, M.D.
Korean J Hepatol.2006;12(4):484-492.   Published online January 1, 2000
      
Comparison of Clinical Outcome Between Patients Continuing and Discontinuing Lamivudine Therapy in Acute Exacerbation After Viral breakthrough During Lamivudine Therapy in Chronic Hepatitis B
Jong Ryul Eun
Korean J Hepatol.2006;12(2):184-190.
      
Correlation of HBV DNA Level and Viral Breakthrough During Lamivudine Therapy for Chronic Hepatitis B
Hee Seung Park , Dong Hyun Lee , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song , Mong Cho
Korean J Hepatol.2006;12(2):173-183.
      
Natural History of HBeAg Negative Chronic Hepatitis B Virus Infection; A Cohort Study
Chang Mo Moon, M.D., Do Young Kim, M.D., Ki Jun Song, Ph.D.1, Ja Kyung Kim, M.D., Hyun Woong Lee, M.D., Jung Min Lee, M.D., Ki Tae Yoon, M.D., Yong Han Paik, M.D., Dong Ki Kim, Ph.D.1, Kwang-Hyub Han, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., and Sang Hoon Ahn, M.D.
Korean J Hepatol.2006;12(2):163-172.
      
Action Mechanism in Immunopathogenesis and Clearance of HBV
Se Jin Im , Young Chul Sung
Korean J Hepatol.2006;12(2):154-162.
      
Clinical Significance and Natural History of "HBeAg Negativity" in Patients with Chronic HBV Infection
Young Sok Lee
Korean J Hepatol.2006;12(2):133-135.
      
The fibrogenic process and the unleashing of acute-on-chronic liver failure
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri
Received January 23, 2019     Accepted May 7, 2019     Published online June 14, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0011    
[Epub ahead of print]
                              
Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
Ratchapong Laiwatthanapaisan, Pimsiri Sripongpun, Naichaya Chamroonkul, Arunee Dechaphunkul, Chirawadee Sathitruangsak, Siwat Sakdejayont, Chanon Kongkamol, Teerha Piratvisuth
Received December 13, 2018     Accepted May 9, 2019     Published online July 17, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0111    
[Epub ahead of print]
                              
1 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 383
TOTAL : 230838